MMP9 and colorectal carcinoma: Since chronic UC is a risk factor for CRC, and since MMP9 expression is associated with poor prognosis in CRC patients [35–38], we were also interesting in assessing the therapeutic benefit of MMP9 inhibition in a model of CRC.